Immuno Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Immuno Oncology Assays Market, By Product & Service

7.1.  Immuno Oncology Assays  Market, By Product & Service, 2023-2032

7.1.1.     Consumables

7.1.1.1.          Market Revenue and Forecast 2020-2032

7.1.2.     Instruments

7.1.2.1.          Market Revenue and Forecast 2020-2032

7.1.3.     Software & Services

7.1.3.1.          Market Revenue and Forecast 2020-2032

Chapter 8.    Global Immuno Oncology Assays Market, By Technology

8.1.  Immuno Oncology Assays  Market, By Technology, 2023-2032

8.1.1.     PCR

8.1.1.1.          Market Revenue and Forecast 2020-2032

8.1.2.     Immunoassay

8.1.2.1.          Market Revenue and Forecast 2020-2032

8.1.3.     NGS

8.1.3.1.          Market Revenue and Forecast 2020-2032

8.1.4.     ISH

8.1.4.1.          Market Revenue and Forecast 2020-2032

8.1.5.     Flow Cytometry

8.1.5.1.          Market Revenue and Forecast 2020-2032

Chapter 9.    Global Immuno Oncology Assays Market, By Indication

9.1.  Immuno Oncology Assays  Market, By Indication, 2023-2032

9.1.1.     Lung Cancer

9.1.1.1.          Market Revenue and Forecast 2020-2032

9.1.2.     Breast Cancer

9.1.2.1.          Market Revenue and Forecast 2020-2032

9.1.3.     Colorectal Cancer

9.1.3.1.          Market Revenue and Forecast 2020-2032

9.1.4.     Bladder Cancer

9.1.4.1.          Market Revenue and Forecast 2020-2032

9.1.5.     Melanoma

9.1.5.1.          Market Revenue and Forecast 2020-2032

9.1.6.     Other Cancers

9.1.6.1.          Market Revenue and Forecast 2020-2032

Chapter 10.Global Immuno Oncology Assays Market, By Application

10.1.          Immuno Oncology Assays  Market, By Application, 2023-2032

10.1.1.  Research Applications

10.1.1.1.       Market Revenue and Forecast 2020-2032

10.1.2.  Clinical Diagnostics

10.1.2.1.       Market Revenue and Forecast 2020-2032

Chapter 11.Global Immuno Oncology Assays  Market, Regional Estimates and Trend Forecast

11.1.          North America

11.1.1.  Market Revenue and Forecast, By Product & Service 2020-2032

11.1.2.  Market Revenue and Forecast, By Technology 2020-2032

11.1.3.  Market Revenue and Forecast, By Indication 2020-2032

11.1.4.  Market Revenue and Forecast, By Application 2020-2032

11.1.5.  U.S.

11.1.5.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.1.5.2.       Market Revenue and Forecast, By Technology 2020-2032

11.1.5.3.       Market Revenue and Forecast, By Indication 2020-2032

11.1.5.4.       Market Revenue and Forecast, By Application 2020-2032

11.1.6.  Rest of North America

11.1.6.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.1.6.2.       Market Revenue and Forecast, By Technology 2020-2032

11.1.6.3.       Market Revenue and Forecast, By Indication 2020-2032

11.1.6.4.       Market Revenue and Forecast, By Application 2020-2032

11.2.          Europe

11.2.1.  Market Revenue and Forecast, By Product & Service 2020-2032

11.2.2.  Market Revenue and Forecast, By Technology 2020-2032

11.2.3.  Market Revenue and Forecast, By Indication 2020-2032

11.2.4.  Market Revenue and Forecast, By Application 2020-2032

11.2.5.  UK

11.2.5.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.2.5.2.       Market Revenue and Forecast, By Technology 2020-2032

11.2.5.3.       Market Revenue and Forecast, By Indication 2020-2032

11.2.5.4.       Market Revenue and Forecast, By Application 2020-2032

11.2.6.  Germany

11.2.6.1.       Market Revenue and Forecast, By Product & Service2020-2032

11.2.6.2.       Market Revenue and Forecast, By Technology 2020-2032

11.2.6.3.       Market Revenue and Forecast, By Indication 2020-2032

11.2.6.4.       Market Revenue and Forecast, By Application 2020-2032

11.2.7.  France

11.2.7.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.2.7.2.       Market Revenue and Forecast, By Technology 2020-2032

11.2.7.3.       Market Revenue and Forecast, By Indication 2020-2032

11.2.7.4.       Market Revenue and Forecast, By Application 2020-2032

11.2.8.  Rest of Europe

11.2.8.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.2.8.2.       Market Revenue and Forecast, By Technology 2020-2032

11.2.8.3.       Market Revenue and Forecast, By Indication 2020-2032

11.2.8.4.       Market Revenue and Forecast, By Application 2020-2032

11.3.          APAC

11.3.1.  Market Revenue and Forecast, By Product & Service 2020-2032

11.3.2.  Market Revenue and Forecast, By Technology 2020-2032

11.3.3.  Market Revenue and Forecast, By Indication 2020-2032

11.3.4.  Market Revenue and Forecast, By Application 2020-2032

11.3.5.  India

11.3.5.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.3.5.2.       Market Revenue and Forecast, By Technology 2020-2032

11.3.5.3.       Market Revenue and Forecast, By Indication 2020-2032

11.3.5.4.       Market Revenue and Forecast, By Application 2020-2032

11.3.6.  China

11.3.6.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.3.6.2.       Market Revenue and Forecast, By Technology 2020-2032

11.3.6.3.       Market Revenue and Forecast, By Indication 2020-2032

11.3.6.4.       Market Revenue and Forecast, By Application 2020-2032

11.3.7.  Japan

11.3.7.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.3.7.2.       Market Revenue and Forecast, By Technology 2020-2032

11.3.7.3.       Market Revenue and Forecast, By Indication 2020-2032

11.3.7.4.       Market Revenue and Forecast, By Application 2020-2032

11.3.8.  Rest of APAC

11.3.8.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.3.8.2.       Market Revenue and Forecast, By Technology 2020-2032

11.3.8.3.       Market Revenue and Forecast, By Indication 2020-2032

11.3.8.4.       Market Revenue and Forecast, By Application 2020-2032

11.4.          MEA

11.4.1.  Market Revenue and Forecast, By Product & Service 2020-2032

11.4.2.  Market Revenue and Forecast, By Technology 2020-2032

11.4.3.  Market Revenue and Forecast, By Indication 2020-2032

11.4.4.  Market Revenue and Forecast, By Application 2020-2032

11.4.5.  GCC

11.4.5.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.4.5.2.       Market Revenue and Forecast, By Technology 2020-2032

11.4.5.3.       Market Revenue and Forecast, By Indication 2020-2032

11.4.5.4.       Market Revenue and Forecast, By Application 2020-2032

11.4.6.  North Africa

11.4.6.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.4.6.2.       Market Revenue and Forecast, By Technology 2020-2032

11.4.6.3.       Market Revenue and Forecast, By Indication 2020-2032

11.4.6.4.       Market Revenue and Forecast, By Application 2020-2032

11.4.7.  South Africa

11.4.7.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.4.7.2.       Market Revenue and Forecast, By Technology 2020-2032

11.4.7.3.       Market Revenue and Forecast, By Indication 2020-2032

11.4.7.4.       Market Revenue and Forecast, By Application 2020-2032

11.4.8.  Rest of MEA

11.4.8.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.4.8.2.       Market Revenue and Forecast, By Technology 2020-2032

11.4.8.3.       Market Revenue and Forecast, By Indication 2020-2032

11.4.8.4.       Market Revenue and Forecast, By Application 2020-2032

11.5.          Latin America

11.5.1.  Market Revenue and Forecast, By Product & Service 2020-2032

11.5.2.  Market Revenue and Forecast, By Technology 2020-2032

11.5.3.  Market Revenue and Forecast, By Indication 2020-2032

11.5.4.  Market Revenue and Forecast, By Application 2020-2032

11.5.5.  Brazil

11.5.5.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.5.5.2.       Market Revenue and Forecast, By Technology 2020-2032

11.5.5.3.       Market Revenue and Forecast, By Indication 2020-2032

11.5.5.4.       Market Revenue and Forecast, By Application 2020-2032

11.5.6.  Rest of LATAM

11.5.6.1.       Market Revenue and Forecast, By Product & Service 2020-2032

11.5.6.2.       Market Revenue and Forecast, By Technology 2020-2032

11.5.6.3.       Market Revenue and Forecast, By Indication 2020-2032

11.5.6.4.       Market Revenue and Forecast, By Application 2020-2032

Chapter 12.   Company Profiles

12.1.                 Thermo Fisher Scientific, Inc. (US)

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.                 F. Hoffmann-La Roche Ltd. (Switzerland)

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.                 Agilent Technologies, Inc. (US)

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.                 Illumina, Inc. (US)

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.                 NanoString Technologies, Inc. (US)

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.                 Sartorius AG (Germany)

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.                 HTG Molecular Diagnostics, Inc. (US)

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.                 QIAGEN N.V. (Netherlands)

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.                 Merck Millipore (US)

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.              PerkinElmer, Inc. (US)

12.10.1.                   Company Overview

12.10.2.                   Product Offerings

12.10.3.                   Financial Performance

12.10.4.                   Recent Initiatives

12.11.              Abbott Laboratories, Inc. (US)

12.11.1.                   Company Overview

12.11.2.                   Product Offerings

12.11.3.                   Financial Performance

12.11.4.                   Recent Initiatives

12.12.              Guardant Health, Inc. (US)

12.12.1.                   Company Overview

12.12.2.                   Product Offerings

12.12.3.                   Financial Performance

12.12.4.                   Recent Initiatives

12.13.              bioMérieux SA (France)

12.13.1.                   Company Overview

12.13.2.                   Product Offerings

12.13.3.                   Financial Performance

12.13.4.                   Recent Initiatives

12.14.              Myriad Genetics, Inc. (US)

12.14.1.                   Company Overview

12.14.2.                   Product Offerings

12.14.3.                   Financial Performance

12.14.4.                   Recent Initiatives

12.15.              MESO SCALE DIAGNOSTICS, LLC. (US)

12.15.1.                   Company Overview

12.15.2.                   Product Offerings

12.15.3.                   Financial Performance

12.15.4.                   Recent Initiatives

12.16.              Seegene Inc. (South Korea)

12.16.1.                   Company Overview

12.16.2.                   Product Offerings

12.16.3.                   Financial Performance

12.16.4.                   Recent Initiatives

12.17.              Bio-Rad Laboratories, Inc. (US)

12.17.1.                   Company Overview

12.17.2.                   Product Offerings

12.17.3.                   Financial Performance

12.17.4.                   Recent Initiatives

12.18.              Charles River Laboratories, Inc. (US)

12.18.1.                   Company Overview

12.18.2.                   Product Offerings

12.18.3.                   Financial Performance

12.18.4.                   Recent Initiatives

12.19.              Olink (Sweden), ASURAGEN, INC. (US)

12.19.1.                   Company Overview

12.19.2.                   Product Offerings

12.19.3.                   Financial Performance

12.19.4.                   Recent Initiatives

12.20.              Invivoscribe, Inc. (US)

12.20.1.                   Company Overview

12.20.2.                   Product Offerings

12.20.3.                   Financial Performance

12.20.4.                   Recent Initiatives

12.21.              Creative Biolabs (US)

12.21.1.                   Company Overview

12.21.2.                   Product Offerings

12.21.3.                   Financial Performance

12.21.4.                   Recent Initiatives

12.22.              ReachBio LLC (US)

12.22.1.                   Company Overview

12.22.2.                   Product Offerings

12.22.3.                   Financial Performance

12.22.4.                   Recent Initiatives

12.23.              NMI Technologietransfer GmbH (Germany)

12.23.1.                   Company Overview

12.23.2.                   Product Offerings

12.23.3.                   Financial Performance

12.23.4.                   Recent Initiatives

Chapter 13.   Research Methodology

13.1.      Primary Research

13.2.       Secondary Research

13.3.        Assumptions

Chapter 14.   Appendix

14.1.          About Us

14.2.      Glossary of Terms